Heteronemin suppresses EGF-induced proliferation through the PI3K/PD-L1 signaling pathways in cholangiocarcinoma

被引:0
作者
Yang, Yu-Chen S. H. [1 ]
Tsai, Chung-Che [2 ,3 ]
Yang, Yung-Ning [4 ,5 ]
Liu, Feng-Cheng [6 ]
Lee, Sheng-Yang [7 ,8 ]
Yang, Jen-Chang [2 ,9 ,10 ,11 ]
Crawford, Dana R. [12 ]
Chiu, Hsien-Chung [13 ,14 ]
Lu, Mei-Chin [15 ,16 ]
Li, Zi-Lin [2 ,3 ]
Chen, Yi-Chen [2 ,3 ]
Chu, Tin-Yi [2 ,3 ]
Whang-Peng, Jacqueline [3 ,17 ]
Lin, Hung-Yun [3 ,18 ,19 ]
Wang, Kuan [2 ]
机构
[1] Taipei Med Univ, Joint Biobank, Off Human Res, Taipei 11031, Taiwan
[2] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Translat Med, Taipei 11031, Taiwan
[3] Taipei Med Univ, Grad Inst Canc Mol Biol & Drug Discovery, Coll Med Sci & Technol, Taipei 11031, Taiwan
[4] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung 84001, Taiwan
[5] I Shou Univ, E Da Hosp, Dept Obstet & Gynecol, Kaohsiung 82445, Taiwan
[6] TriServ Gen Hosp, Div Rheumatol Immunol & Allergy, Taipei, Taiwan
[7] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei 11031, Taiwan
[8] Taipei Med Univ, Wan Fang Med Ctr, Dent, Taipei 11031, Taiwan
[9] Taipei Med Univ, Coll Biomed Engn, Int PhD Program Biomed Engn, Taipei 11031, Taiwan
[10] Taipei Med Univ, Res Ctr Biomed Device, Taipei 11031, Taiwan
[11] Taipei Med Univ, Res Ctr Digital Oral Sci & Technol, Taipei 11031, Taiwan
[12] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA
[13] Natl Def Med Ctr, Sch Dent, Dept Periodontol, 325,Sec 2,Chenggong Rd, Taipei 11490, Taiwan
[14] Triserv Gen Hosp, Taipei 11490, Taiwan
[15] Natl Museum Marine Biol & Aquarium, Pingtung 94450, Taiwan
[16] Natl Dong Hwa Univ, Grad Inst Marine Biol, Pingtung 94450, Taiwan
[17] Taipei Med Univ, Wan Fang Hosp, Canc Ctr, Taipei 11031, Taiwan
[18] Taipei Med Univ, Taipei Med Univ Hosp, Tradit Herbal Med Res Ctr, Taipei 11031, Taiwan
[19] Taipei Med Univ, TMU Res Ctr Canc Translat Med, Taipei 11031, Taiwan
关键词
PD-L1; EGF; cancer immunotherapy; cholangiocarcinoma; heteronemin; EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; GEFITINIB RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; BREAST-CANCER; CELLS; KRAS; ACTIVATION; INHIBITORS;
D O I
10.3892/or.2025.8865
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epidermal growth factor (EGF) binds with its surface receptor to stimulate gene expression and cancer cell proliferation. EGF stimulates cancer cell growth via phosphoinositide 3-kinase (PI3K) and programmed cell death ligand 1 (PD-L1) pathways. As an integrin alpha v beta 3 antagonist, heteronemin exhibits potent cytotoxic effects against cancer cells. It inhibits critical signal transduction pathways promoted by the EGF. In the current study, EGF-induced signal activation and proliferative effects were investigated in cholangiocarcinoma cells and its molecular targets using qPCR and western blotting analyses. In addition, cell viability assays were performed to assess the growth effects of EGF and heteronemin. Heteronemin reversed the effects of EGF and was further enhanced by blockage of PI3K's activity. In summary, EGF stimulates cholangiocarcinoma cell growth. On the other hand, heteronemin inhibited PI3K activation and PD-L1 expression to reverse the stimulative effects of EGF-induced gene expression and proliferation in cholangiocarcinoma cells.
引用
收藏
页数:13
相关论文
共 51 条
  • [1] Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors
    Amelia, Tasia
    Kartasasmita, Rahmana Emran
    Ohwada, Tomohiko
    Tjahjono, Daryono Hadi
    [J]. MOLECULES, 2022, 27 (03):
  • [2] How Compensatory Mechanisms and Adaptive Rewiring Have Shaped Our Understanding of Therapeutic Resistance in Cancer
    Bergholz, Johann S.
    Zhao, Jean J.
    [J]. CANCER RESEARCH, 2021, 81 (24) : 6074 - 6077
  • [3] Brand TM, 2011, DISCOV MED, V12, P419
  • [4] A Marine Terpenoid, Heteronemin, Induces Both the Apoptosis and Ferroptosis of Hepatocellular Carcinoma Cells and Involves the ROS and MAPK Pathways
    Chang, Wen-Tsan
    Bow, Yung-Ding
    Fu, Pei-Jung
    Li, Chia-Yang
    Wu, Chang-Yi
    Chang, Yi-Hua
    Teng, Yen-Ni
    Li, Ruei-Nian
    Lu, Mei-Chin
    Liu, Yi-Chang
    Chiu, Chien-Chih
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [5] Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells
    Chen, Mingshui
    Sharma, Aditi
    Lin, Yanling
    Wu, Yanheng
    He, Qi
    Gu, Yushu
    Xu, Zhi Ping
    Monteiro, Michael
    Gu, Wenyi
    [J]. BMC CANCER, 2019, 19 (1)
  • [6] Chong ZZ, 2007, HISTOL HISTOPATHOL, V22, P1251, DOI 10.14670/HH-22.1251
  • [7] EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT
    Choudhary, Kumari Sonal
    Rohatgi, Neha
    Halldorsson, Skarphedinn
    Briem, Eirikur
    Gudjonsson, Thorarinn
    Gudmundsson, Steinn
    Rolfsson, Ottar
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2016, 12 (06)
  • [8] Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition
    Chung, Cheng-Chin
    Huang, Tung-Yung
    Chu, Hung-Ru
    De Luca, Roberto
    Candelotti, Elena
    Huang, Chi-Hung
    Yang, Yu-Chen S. H.
    Incerpi, Sandra
    Pedersen, Jens Z.
    Lin, Chi-Yu
    Huang, Haw-Ming
    Lee, Sheng-Yang
    Li, Zi-Lin
    ChangOu, Chun A.
    Li, Wen-Shan
    Davis, Paul J.
    Lin, Hung-Yun
    Whang-Peng, Jacqueline
    Wang, Kuan
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2022, 161
  • [9] EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition
    Claperon, Audrey
    Mergey, Martine
    Thanh Huong Nguyen Ho-Bouldoires
    Vignjevic, Danijela
    Wendum, Dominique
    Chretien, Yves
    Merabtenes, Fatiha
    Frazao, Alexandra
    Paradis, Valerie
    Housset, Chantal
    Guedj, Nathalie
    Fouassier, Laura
    [J]. JOURNAL OF HEPATOLOGY, 2014, 61 (02) : 325 - 332
  • [10] Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma
    Cloughesy, Tim F.
    Yoshimoto, Koji
    Nghiemphu, Phioanh
    Brown, Kevin
    Dang, Julie
    Zhu, Shaojun
    Hsueh, Teli
    Chen, Yinan
    Wang, Wei
    Youngkin, David
    Liau, Linda
    Martin, Neil
    Becker, Don
    Bergsneider, Marvin
    Lai, Albert
    Green, Richard
    Oglesby, Tom
    Koleto, Michael
    Trent, Jeff
    Horvath, Steve
    Mischel, Paul S.
    Mellinghoff, Ingo K.
    Sawyers, Charles L.
    [J]. PLOS MEDICINE, 2008, 5 (01): : 139 - 151